Denver, a city known for its active lifestyle and healthy population, is experiencing a significant uptake in GLP-1 drugs, such as Ozempic and Mounjaro, extending beyond their approved use for weight loss and diabetes management. Residents are turning to these medications for perceived benefits in anti-aging, longevity, and overall performance enhancement, a trend local medical professionals describe as part of a broader "biohacking" culture.
Dr. Edward Cobb, medical director at The Firm Med Spa in Lone Tree, a Denver suburb, notes that many of his patients, who are often already at peak fitness, seek these drugs to optimize their bodies further, aiming for "97% or 98% peak fitness." He explained that some patients use these drugs for "performance enhancement as opposed to treating problems." Some are also employing "microdosing" techniques, using lower-than-standard doses, with anecdotal reports of reduced inflammation and joint pain. Research has also indicated that GLP-1 drugs might delay or reduce the need for knee replacements.
This pursuit of optimization is particularly prevalent among women in their 40s and 50s, many of whom are in perimenopause or menopause and seeking to combat hormonal weight gain. Julie King, owner of The Firm Med Spa, stated that for many users, the appeal is not just slimming down but also "staying young, staying lean and staying at peak performance." She added that Denver residents often desire "natural and subtle" aesthetic enhancements, aligning with the city's focus on understated appearance despite a strong emphasis on fitness.
The Rise of Unregulated Markets
The demand for these drugs, especially among individuals who do not medically qualify for traditional prescriptions or insurance coverage, has led to the emergence of an underground market. Some Denver residents are reportedly bypassing healthcare providers altogether, seeking unregulated versions of GLP-1 products. Reports indicate that several retail stores in the Denver area are openly selling products labeled "not for human consumption" or "research chemicals," often sourced from China. These products, sold without prescription, come at a significantly lower cost than medically supervised treatments.
However, medical professionals strongly caution against this practice. Nurse practitioner Ashley DeGrush expressed alarm, stating, "You have no idea where they're coming from. They could be made in a bath tub." The U.S. Food and Drug Administration (FDA) has reported at least two deaths and 28 serious outcomes linked to counterfeit weight-loss injections. Unregulated substances pose significant health risks due to the lack of quality control and testing required for legitimate medications.
Dr. Cobb suggested that these unregulated sales exploit a legal loophole where chemicals can be sold for "lab research" without being subject to the same controls as pharmaceuticals. The FDA has begun issuing warning letters to companies selling unapproved, injectable GLP-1 dupes under the guise of research, highlighting that such sales violate regulations and pose serious health dangers. Despite Colorado's reputation as one of the healthiest states, prescription data previously indicated a high demand for GLP-1 drugs, with Denver leading the state, although more recent data shows Denver falling outside the top 20 usage areas nationally, suggesting that off-the-books transactions may be a significant factor.